Joellen M. Schildkraut

24.4k total citations · 1 hit paper
219 papers, 8.7k citations indexed

About

Joellen M. Schildkraut is a scholar working on Reproductive Medicine, Genetics and Oncology. According to data from OpenAlex, Joellen M. Schildkraut has authored 219 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Reproductive Medicine, 85 papers in Genetics and 60 papers in Oncology. Recurrent topics in Joellen M. Schildkraut's work include Ovarian cancer diagnosis and treatment (93 papers), BRCA gene mutations in cancer (49 papers) and Cancer Risks and Factors (32 papers). Joellen M. Schildkraut is often cited by papers focused on Ovarian cancer diagnosis and treatment (93 papers), BRCA gene mutations in cancer (49 papers) and Cancer Risks and Factors (32 papers). Joellen M. Schildkraut collaborates with scholars based in United States, United Kingdom and Canada. Joellen M. Schildkraut's co-authors include Andrew Berchuck, Melissa L. Bondy, Elizabeth B. Claus, Margaret Wrensch, Joseph L. Wiemels, Patricia G. Moorman, Cathrine Hoyo, Susan K. Murphy, Amy Murtha and Brian Calingaert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Statistical Association.

In The Last Decade

Joellen M. Schildkraut

212 papers receiving 8.5k citations

Hit Papers

Invasive Epithelial Ovarian Cancer Survival by Histotype ... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
    2018 345 citations Lauren C. Peres, Holly R. Harris et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joellen M. Schildkraut United States 51 2.4k 2.3k 2.2k 1.7k 1.2k 219 8.7k
Clemens Tempfer Austria 52 2.6k 1.1× 1.9k 0.8× 796 0.4× 1.9k 1.1× 1.9k 1.6× 374 9.2k
Britton Trabert United States 41 2.8k 1.2× 2.0k 0.9× 823 0.4× 1.8k 1.0× 1.2k 1.0× 173 7.7k
Anne Zeleniuch‐Jacquotte United States 52 1.0k 0.4× 2.1k 0.9× 1.9k 0.8× 3.3k 1.9× 633 0.5× 168 8.9k
Hoda Anton‐Culver United States 61 897 0.4× 2.0k 0.9× 2.4k 1.1× 4.7k 2.7× 646 0.5× 265 12.1k
Steinar Tretli Norway 64 999 0.4× 2.6k 1.1× 1.3k 0.6× 4.8k 2.8× 487 0.4× 243 11.4k
Saundra S. Buys United States 36 1.5k 0.6× 1.5k 0.6× 1.8k 0.8× 2.1k 1.2× 643 0.5× 137 6.1k
Patricia G. Moorman United States 41 1.2k 0.5× 1.7k 0.7× 2.0k 0.9× 4.8k 2.8× 595 0.5× 135 8.7k
Diane C. Bodurka United States 54 3.9k 1.7× 1.2k 0.5× 635 0.3× 3.4k 2.0× 3.2k 2.7× 210 10.7k
James V. Lacey United States 45 1.1k 0.5× 914 0.4× 1.5k 0.7× 2.5k 1.4× 1.4k 1.2× 133 6.7k
Timothy R. Rebbeck United States 56 1.6k 0.7× 3.0k 1.3× 5.6k 2.5× 3.7k 2.1× 260 0.2× 257 12.7k

Countries citing papers authored by Joellen M. Schildkraut

Since Specialization
Citations

This map shows the geographic impact of Joellen M. Schildkraut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joellen M. Schildkraut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joellen M. Schildkraut more than expected).

Fields of papers citing papers by Joellen M. Schildkraut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joellen M. Schildkraut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joellen M. Schildkraut. The network helps show where Joellen M. Schildkraut may publish in the future.

Co-authorship network of co-authors of Joellen M. Schildkraut

This figure shows the co-authorship network connecting the top 25 collaborators of Joellen M. Schildkraut. A scholar is included among the top collaborators of Joellen M. Schildkraut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joellen M. Schildkraut. Joellen M. Schildkraut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marks, Jeffrey R., Lindsay J. Collin, David A. Nix, et al.. (2025). Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals. Cancer Research. 85(9). 1725–1737. 1 indexed citations
2.
Davidson, Natalie R., Mollie E. Barnard, Amy Campbell, et al.. (2024). Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms. Cancer Epidemiology Biomarkers & Prevention. 33(8). 1114–1125. 4 indexed citations
3.
Pharoah, Paul D.P., Simon A. Gayther, Ani Manichaikul, et al.. (2023). Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility. Cancer Epidemiology Biomarkers & Prevention. 32(9). 1198–1207. 4 indexed citations
4.
Harris, Holly R., Lauren C. Peres, Courtney E. Johnson, et al.. (2023). Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer. Obstetrics and Gynecology. 141(6). 1124–1138. 7 indexed citations
5.
Harris, Holly R., Kristin A. Guertin, Courtney E. Johnson, et al.. (2022). Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium. International Journal of Cancer. 151(8). 1228–1239. 12 indexed citations
6.
Bandera, Elisa V., Traci N. Bethea, Fabian Camacho, et al.. (2021). Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium. Cancer Epidemiology Biomarkers & Prevention. 30(9). 1660–1668. 5 indexed citations
7.
Jia, Guochong, Xiang Shu, Joellen M. Schildkraut, et al.. (2020). Genetically predicted circulating protein biomarkers and ovarian cancer risk. Gynecologic Oncology. 160(2). 506–513. 14 indexed citations
8.
Cornish, Alex J., Ben Kinnersley, Philip Law, et al.. (2020). Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study. British Journal of Cancer. 124(2). 447–454. 9 indexed citations
9.
Anderson, Roger T., Lauren C. Peres, Fabian Camacho, et al.. (2018). Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study. Journal of Women s Health. 28(2). 284–293. 13 indexed citations
10.
Moorman, Patricia G., Nadine J. Barrett, Frances Wang, et al.. (2018). Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women. Journal of Women s Health. 28(4). 444–451. 15 indexed citations
11.
Pearce, Celeste Leigh, Daniel O. Stram, Roberta B. Ness, et al.. (2015). Population Distribution of Lifetime Risk of Ovarian Cancer in the United States. Cancer Epidemiology Biomarkers & Prevention. 24(4). 671–676. 71 indexed citations
12.
Grant, Delores J., Cathrine Hoyo, Leah Gerber, et al.. (2012). Association of Uridine Diphosphate-Glucuronosyltransferase 2B Gene Variants with Serum Glucuronide Levels and Prostate Cancer Risk. Genetic Testing and Molecular Biomarkers. 17(1). 3–9. 18 indexed citations
13.
Hoyo, Cathrine, Susan K. Murphy, Joellen M. Schildkraut, et al.. (2012). IGF2RGenetic Variants, Circulating IGF2 Concentrations and Colon Cancer Risk in African Americans and Whites. Disease Markers. 32(2). 133–141. 15 indexed citations
14.
Stevens, Kristen N., Linda E. Kelemen, Xianshu Wang, et al.. (2012). Common Variation in Nemo-Like Kinase Is Associated with Risk of Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 21(3). 523–528. 8 indexed citations
15.
Gaudet, Mia M., Michael F. Press, Robert W. Haile, et al.. (2011). Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Research and Treatment. 130(2). 587–597. 145 indexed citations
16.
Neklason, Deborah W., Ann G. Schwartz, Hoda Anton‐Culver, et al.. (2011). Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer. 11(1). 424–424. 37 indexed citations
17.
Neklason, Deborah W., Richard A. Kerber, Hoda Anton‐Culver, et al.. (2008). Common Familial Colorectal Cancer Linked to Chromosome 7q31: A Genome-Wide Analysis. Cancer Research. 68(21). 8993–8997. 27 indexed citations
18.
Kelemen, Linda E., Thomas A. Sellers, Joellen M. Schildkraut, et al.. (2008). Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk. Cancer Research. 68(7). 2498–2506. 50 indexed citations
19.
Moorman, Patricia G., Andrew Berchuck, Brian Calingaert, Susan Halabi, & Joellen M. Schildkraut. (2005). Antidepressant Medication Use for and Risk of Ovarian Cancer. Obstetrics and Gynecology. 105(4). 725–730. 21 indexed citations
20.
Skinner, Celette Sugg, Joellen M. Schildkraut, Donald A. Berry, et al.. (2002). Pre-Counseling Education Materials for BRCA Testing: Does Tailoring Make a Difference?. Genetic Testing. 6(2). 93–105. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clemens Tempfer Breakdown of academic impact, for papers by Britton Trabert Breakdown of academic impact, for papers by Anne Zeleniuch‐Jacquotte Breakdown of academic impact, for papers by Hoda Anton‐Culver Breakdown of academic impact, for papers by Steinar Tretli Breakdown of academic impact, for papers by Saundra S. Buys Breakdown of academic impact, for papers by Patricia G. Moorman Breakdown of academic impact, for papers by Diane C. Bodurka Breakdown of academic impact, for papers by James V. Lacey Breakdown of academic impact, for papers by Timothy R. Rebbeck
Rankless by CCL
2026